Mexiletine Hydrochloride

CAS 5370-01-4 8 current records 3 historicalSmall Molecule

Who holds supplier records for Mexiletine Hydrochloride? 8 organisations hold a current record for Mexiletine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6) and Spain (2).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Mexiletine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/mexiletine-hydrochloride

Reading the evidence

  • 8 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    6 of the 8 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (8)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Mexiletine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Mexiletine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Mexiletine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
HETERO DRUGS LIMITED HyderabadIN
CEP 2021-421 - Rev 01
Mexiletine hydrochloride
Sept 2025—
AGC PHARMA CHEMICALS EUROPE S.L.U. Malgrat De MarES
CEP 2017-107 - Rev 03
Mexiletine hydrochloride
Apr 2024Inspected May 2024
Spain
BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. HyderabadIN
R0-CEP 2020-384 - Rev 00
Mexiletine hydrochloride
May 2022—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
R1-CEP 2014-057 - Rev 01
Mexiletine hydrochloride
Jan 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Mexiletine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 3 historical records
  • SLOVAKOFARMA AS
    Inactive DMF 14442 · filed Oct 1999
  • ICN HUNGARY CO LTD
    Inactive DMF 10376 · filed Jul 1993
  • South Africa · Inactive DMF 9786 · filed Jun 1992

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Mexiletine Hydrochloride is an antiarrhythmic medication that is primarily used to treat irregular heartbeats and certain types of neuropathic pain. It works by stabilizing the heart's electrical activity and decreasing the sensitivity of heart tissue to abnormal electrical impulses.

Chemical identity

IUPAC name
1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride
Canonical SMILES
CC1=C(C(=CC=C1)C)OCC(C)N.Cl
InChIKey
NFEIBWMZVIVJLQ-UHFFFAOYSA-N
Synonyms
Mexitil API, katen, ko 1173 cl, ko-1173, ko-1173 cl, ko-1173-cl, mexiletine hcl, mexitil, nsc-758639

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Antiarrhythmic

Therapeutic areas

CardiovascularNeurology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Mexiletine Hydrochloride?

8 organisations hold an active US FDA Type II Drug Master File or a CEP for Mexiletine Hydrochloride: Alembic Pharmaceuticals Limited (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), Hetero Drugs Limited (India), COHANCE LIFESCIENCES LTD (India), KALINTIS HEALTHCARE PVT LTD (India), Macleods Pharmaceuticals Ltd. (India), MEDICHEM SA (Spain) and AGC PHARMA CHEMICALS EUROPE SLU (Spain). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Mexiletine Hydrochloride Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 24714), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 34668), Hetero Drugs Limited (DMF 35983), COHANCE LIFESCIENCES LTD (DMF 34958), KALINTIS HEALTHCARE PVT LTD (DMF 35146), Macleods Pharmaceuticals Ltd. (DMF 36097) and MEDICHEM SA (DMF 9257). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Mexiletine Hydrochloride records mean?

3 organisations have only inactive Type II DMFs for Mexiletine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Mexiletine Hydrochloride have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Mexiletine Hydrochloride on the EDQM register, including HETERO DRUGS LIMITED Hyderabad (IN), AGC PHARMA CHEMICALS EUROPE S.L.U. Malgrat De Mar (ES), BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. Hyderabad (IN) and ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Mexiletine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Mexiletine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.